| Website | coriumgroup.com |
| Category | BioTech |
| Phone | 650-298-8255 |
| Employees |
| TOTAL | $40M |
| FUNDING TOTAL | $40M |
| Series C, 9/07 Essex Woodlands Health Ventures Quantum Technology Partners Aphelion Capital | $40M |
Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.
